At AbbVie, we partner to achieve two important outcomes: deliver
innovative medicines and make a remarkable impact on people’s lives.
We start with a highly integrated approach to developing and
sustaining our partnerships. We work as one connected unit with a
commitment to establishing collaborations across the development
continuum that will ultimately benefit patients and fuel
Whether partnering with a business, academia or consortia, our goal
is to create long-term mutually beneficial relationships. For example,
for a smaller biotech partner, AbbVie’s global medical affairs and
commercial reach may enable their product to benefit patients
worldwide. Large pharmaceutical partnerships allow each company to
contribute the strengths of their organization.
With a shared vision as our foundation, we align our capabilities to
conduct groundbreaking science and bring innovative medicines to
societies around the globe. From start to finish, we manage our
partnerships for success—from early identification and mitigation of
risks to shared accountability and reward for successful outcomes. Our
partners and our strong team help make this possible.
Focused on identifying and evaluating new opportunities that
complement and enhance our existing internal innovation strategies.
S&E works in close partnership with our R&D and commercial
teams, BD&A and Ventures to thoughtfully address each opportunity.
Evaluates a variety of partnership structures to meet the needs of
both parties. BD&A works closely with S&E, and our commercial
and R&D organizations to evaluate new opportunities.
Highly successful partnerships result from an ongoing commitment to
realize a shared vision. At AbbVie, we have a dedicated team that is
involved in all aspects of the partnership from contracting through
commercialization to ensure positive outcomes for all parties.
We strategically invest in transformational scientific opportunities
to augment our core R&D interests and gain access to
next-generation science and proven scientific leaders. Our expertise
in drug development and commercialization can be a valuable resource
to even the earliest stage companies.